[HTML][HTML] Immune dysregulation as a driver of idiopathic pulmonary fibrosis
K Shenderov, SL Collins, JD Powell… - The Journal of clinical …, 2021 - Am Soc Clin Investig
Idiopathic pulmonary fibrosis (IPF) affects hundreds of thousands of people worldwide,
reducing their quality of life and leading to death from respiratory failure within years of …
reducing their quality of life and leading to death from respiratory failure within years of …
PM2. 5 exposure and asthma development: the key role of oxidative stress
K Liu, S Hua, L Song - Oxidative Medicine and Cellular …, 2022 - Wiley Online Library
Oxidative stress is defined as the imbalance between reactive oxygen species (ROS)
production and the endogenous antioxidant defense system, leading to cellular damage …
production and the endogenous antioxidant defense system, leading to cellular damage …
[HTML][HTML] Type 2 immunity in tissue repair and fibrosis
Type 2 immunity is characterized by the production of IL-4, IL-5, IL-9 and IL-13, and this
immune response is commonly observed in tissues during allergic inflammation or infection …
immune response is commonly observed in tissues during allergic inflammation or infection …
Targeting metabolic dysregulation for fibrosis therapy
Fibrosis is the abnormal deposition of extracellular matrix, which can lead to organ
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …
The therapy of idiopathic pulmonary fibrosis: what is next?
V Somogyi, N Chaudhuri, SE Torrisi… - European …, 2019 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease, characterised by progressive scarring of the lung and associated with a high …
disease, characterised by progressive scarring of the lung and associated with a high …
Targeting key proximal drivers of type 2 inflammation in disease
NA Gandhi, BL Bennett, NMH Graham… - Nature reviews Drug …, 2016 - nature.com
Systemic type 2 inflammation encompassing T helper 2 (TH2)-type responses is emerging
as a unifying feature of both classically defined allergic diseases, such as asthma, and a …
as a unifying feature of both classically defined allergic diseases, such as asthma, and a …
[HTML][HTML] Idiopathic pulmonary fibrosis (IPF): an overview
SL Barratt, A Creamer, C Hayton… - Journal of clinical …, 2018 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised by chronic,
progressive scarring of the lungs and the pathological hallmark of usual interstitial …
progressive scarring of the lungs and the pathological hallmark of usual interstitial …
[HTML][HTML] Airway remodeling in asthma: what really matters
Airway remodeling is generally quite broadly defined as any change in composition,
distribution, thickness, mass or volume and/or number of structural components observed in …
distribution, thickness, mass or volume and/or number of structural components observed in …
[HTML][HTML] Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
L Chávez-Galán, ML Olleros, D Vesin… - Frontiers in …, 2015 - frontiersin.org
Monocytes are considered to be precursor cells of the mononuclear phagocytic system, and
macrophages are one of the leading members of this cellular system. Macrophages play …
macrophages are one of the leading members of this cellular system. Macrophages play …
[HTML][HTML] Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets
B Ballester, J Milara, J Cortijo - International journal of molecular sciences, 2019 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary
disease with a median survival of 2–4 years after diagnosis. A significant number of IPF …
disease with a median survival of 2–4 years after diagnosis. A significant number of IPF …